EUVIMEDEUVIMED entdecken
Crossref

Quality of life measurement in rosacea. Position statement of the European Academy of Dermatology and Venereology Task Forces on Quality of Life and Patient Oriented Outcomes and Acne, Rosacea and Hidradenitis Suppurativa

P V Chernyshov iD, A Y Finlay iD, L Tomas-Aragones, M Steinhoff, L Manolache, N Pustisek, C Dessinioti iD, A Svensson iD, S E Marron, A Bewley iD, C Salavastru, B Dréno und 11 weitere

Journal of the European Academy of Dermatology and Venereology · 2023

DOI: 10.1111/jdv.18918 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of the European Academy of Dermatology and Venereology, 2023. Verfasst von P V Chernyshov und 22 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology and Venereology, National Medical University, Kiev, Ukraine. Hauptthemen laut MEDLINE: Hidradenitis Suppurativa, Venereology, Dermatology, Acne Vulgaris. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 126 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The European Academy of Dermatology and Venereology (EADV) Task Forces (TFs) on Quality of Life (QoL) and Patient‐Oriented Outcomes and Acne, Rosacea and Hidradenitis Suppurativa (ARHS) do not recommend the use of any generic instrument as a single method of Health Related (HR) QoL assessment in rosacea, except when comparing quimp (quality of life impairment) in rosacea patients with that in other non‐dermatologic skin diseases and/or healthy controls. The EADV TFs on QoL and Patient‐Oriented Outcomes and ARHS recommend the use of the dermatology‐specific HRQoL instrument the Dermatology Life Quality Index (DLQI) and the rosacea‐specific HRQoL instrument RosaQoL in rosacea patients. The DLQI minimal clinically important difference may be used as a marker of clinical efficacy of the treatment and DLQI score banding of 0 or 1 corresponding to no effect on patients' HRQoL could be an important treatment goal. This information may be added to consensuses and guidelines for rosacea.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hidradenitis SuppurativaVenereologyDermatologyAcne VulgarisRosaceaHumansQuality of Life

Autor:innen und Institutionen

  • Department of Dermatology and Venereology, National Medical University, Kiev, Ukraine.
  • Division of Infection and Immunity, School of Medicine, Cardiff University, Cardiff, UK.
  • Department of Psychology, University of Zaragoza, Zaragoza, Spain.
  • Department of Dermatology and Venereology, Hamad Medical Corporation, Doha, Qatar.
  • Dermatology Institute, Academic Health System, Hamad Medical Corporation, Doha, Qatar.
  • Translational Research Institute, Academic Health System, Hamad Medical Corporation, Doha, Qatar.

ORCID-Profile: P V Chernyshov, A Y Finlay, C Dessinioti, A Svensson, A Bewley, D Koumaki, D Linder, M Augustin, S S Salek, V Bettoli, J С Szepietowski, C C Zouboulis

Zitieren

APA

Chernyshov, P. V., Finlay, A. Y., Tomas-Aragones, L., Steinhoff, M., Manolache, L., Pustisek, N., Dessinioti, C., Svensson, A., Marron, S. E., Bewley, A., Salavastru, C., Dréno, B., Suru, A., Koumaki, D., Linder, D., Evers, A. W. M., Abeni, D., Augustin, M., Salek, S. S., …, & Zouboulis, C. C. (2023). Quality of life measurement in rosacea. Position statement of the European Academy of Dermatology and Venereology Task Forces on Quality of Life and Patient Oriented Outcomes and Acne, Rosacea and Hidradenitis Suppurativa. Journal of the European Academy of Dermatology and Venereology. https://doi.org/10.1111/jdv.18918

Vancouver

Chernyshov PV, Finlay AY, Tomas-Aragones L, Steinhoff M, Manolache L, Pustisek N, et al. Quality of life measurement in rosacea. Position statement of the European Academy of Dermatology and Venereology Task Forces on Quality of Life and Patient Oriented Outcomes and Acne, Rosacea and Hidradenitis Suppurativa. Journal of the European Academy of Dermatology and Venereology. 2023. doi:10.1111/jdv.18918

BibTeX
@article{Chernyshov2023,
  author = {Chernyshov, P V and Finlay, A Y and Tomas-Aragones, L and Steinhoff, M and Manolache, L and Pustisek, N and Dessinioti, C and Svensson, A and Marron, S E and Bewley, A and Salavastru, C and Dréno, B and Suru, A and Koumaki, D and Linder, D and Evers, A W M and Abeni, D and Augustin, M and Salek, S S and Nassif, A and Bettoli, V and Szepietowski, J С and Zouboulis, C C},
  title = {Quality of life measurement in rosacea. Position statement of the European Academy of Dermatology and Venereology Task Forces on Quality of Life and Patient Oriented Outcomes and Acne, Rosacea and Hidradenitis Suppurativa},
  journal = {Journal of the European Academy of Dermatology and Venereology},
  year = {2023},
  doi = {10.1111/jdv.18918}
}
Kostenlos starten →